Pakistan's PPMA Complains Of Delays In Government Drug-Pricing Update
This article was originally published in PharmAsia News
Executive Summary
Pakistan pharmaceutical companies complain government delays in updating its drug-pricing policy are costing the industry revenues largely frozen for a dozen years.